{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:30:30Z","timestamp":1761895830961},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T00:00:00Z","timestamp":1390262400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s00125-014-3168-1","type":"journal-article","created":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T06:16:11Z","timestamp":1390198571000},"page":"868-877","source":"Crossref","is-referenced-by-count":11,"title":["A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment"],"prefix":"10.1007","volume":"57","author":[{"name":"for the Clinical Trials Study Group of the German Association for the Study of Diabetes (Deutsche Diabetes-Gesellschaft)","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Nauck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"Haastert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Trautner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich A.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias A.","family":"Nauck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lutz","family":"Heinemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,21]]},"reference":[{"key":"3168_CR1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"DCCT Research Group","year":"1993","unstructured":"DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes. N Engl J Med 329:977\u2013986","journal-title":"N Engl J Med"},{"key":"3168_CR2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/dmrr.614","volume":"22","author":"JC Pickup","year":"2006","unstructured":"Pickup JC, Kidd J, Burmiston S, Yemane N (2006) Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability. Diabetes Metab Res Rev 22:232\u2013237","journal-title":"Diabetes Metab Res Rev"},{"key":"3168_CR3","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.2337\/diacare.26.9.2598","volume":"26","author":"P Raskin","year":"2003","unstructured":"Raskin P, Bode BW, Marks JB et al (2003) Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care 26:2598\u20132603","journal-title":"Diabetes Care"},{"key":"3168_CR4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0738-3991(96)00941-X","volume":"29","author":"M Gr\u00fcsser","year":"1996","unstructured":"Gr\u00fcsser M, Hartmann P, Schlottmann N, Joergens V (1996) Structured treatment and teaching programme for type 2 diabetic patients on conventional insulin treatment: evaluation of reimbursement policy. Patient Educ Couns 29:123\u2013130","journal-title":"Patient Educ Couns"},{"key":"3168_CR5","unstructured":"Bundes\u00e4rztekammer (B\u00c4K) KBK (2013) Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2012) Nationale Versorgungs-Leitlinie Diabetes. Strukturierte Schulungsprogramme \u2013 Langfassung. \u00c4rztliches Zentrum f\u00fcr Qualit\u00e4t in der Medizin, Berlin, Germany [in German]; available from www.versorgungsleitlinien.de\/themen\/diabetes2\/dm2_schulung\/index_html (accessed 6 January 2014)"},{"key":"3168_CR6","first-page":"587","volume":"106","author":"MA Nauck","year":"2009","unstructured":"Nauck MA, El-Ouaghlidi A, Vardarli I (2009) Blutzuckerselbstkontrolle bei Diabetes mellitus: Pl\u00e4doyer f\u00fcr ein individuelles Selbstkontrollkonzept\/Self-monitoring of blood glucose in diabetes mellitus: arguments for an individualized approach. Dtsch \u00c4rzteblatt Int 106:587\u2013594 [article in German]","journal-title":"Dtsch \u00c4rzteblatt Int"},{"key":"3168_CR7","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.2337\/diacare.25.11.1928","volume":"25","author":"U Schwedes","year":"2002","unstructured":"Schwedes U, Siebolds M, Mertes G (2002) Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 25:1928\u20131932","journal-title":"Diabetes Care"},{"key":"3168_CR8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1262-3636(07)70073-3","volume":"29","author":"B Guerci","year":"2003","unstructured":"Guerci B, Drouin P, Grange V et al (2003) Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 29:587\u2013594","journal-title":"Diabetes Metab"},{"key":"3168_CR9","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1463-1326.2008.00889.x","volume":"10","author":"AH Barnett","year":"2008","unstructured":"Barnett AH, Krentz AJ, Strojek K et al (2008) The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab 10:1239\u20131247","journal-title":"Diabetes Obes Metab"},{"key":"3168_CR10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11606-008-0830-7","volume":"24","author":"GH Murata","year":"2009","unstructured":"Murata GH, Duckworth WC, Shah JH, Wendel CS, Mohler MJ, Hoffman RM (2009) Blood glucose monitoring is associated with better glycemic control in type 2 diabetes: a database study. J Gen Intern Med 24:48\u201352","journal-title":"J Gen Intern Med"},{"key":"3168_CR11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1463-1326.2006.00676.x","volume":"10","author":"HS Chen","year":"2008","unstructured":"Chen HS, Wu TE, Jap TS, Lin SH, Hsiao LC, Lin HD (2008) Improvement of glycaemia control in subjects with type 2 diabetes by self-monitoring of blood glucose: comparison of two management programs adjusting bedtime insulin dosage. Diabetes Obes Metab 10:34\u201340","journal-title":"Diabetes Obes Metab"},{"key":"3168_CR12","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2337\/diacare.26.6.1759","volume":"26","author":"GH Murata","year":"2003","unstructured":"Murata GH, Shah JH, Hoffman RM et al (2003) Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES). Diabetes Care 26:1759\u20131763","journal-title":"Diabetes Care"},{"key":"3168_CR13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00125-005-0083-5","volume":"49","author":"S Martin","year":"2006","unstructured":"Martin S, Schneider B, Heinemann L et al (2006) Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia 49:271\u2013278","journal-title":"Diabetologia"},{"key":"3168_CR14","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1464-5491.2005.01546.x","volume":"22","author":"M Franciosi","year":"2005","unstructured":"Franciosi M, Pellegrini F, de Berardis G et al (2005) Self-monitoring of blood glucose in non-insulin-treated diabetic patients: a longitudinal evaluation of its impact on metabolic control. Diabet Med J Br Diabet Assoc 22:900\u2013906","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"3168_CR15","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1136\/bmj.39534.571644.BE","volume":"336","author":"MJ O'Kane","year":"2008","unstructured":"O'Kane MJ, Bunting B, Copeland M, Coates VE (2008) Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. Brit Med J 336:1174\u20131177","journal-title":"Brit Med J"},{"key":"3168_CR16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/bmj.39247.447431.BE","volume":"335","author":"A Farmer","year":"2007","unstructured":"Farmer A, Wade A, Goyder E et al (2007) Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. Brit Med J 335:132","journal-title":"Brit Med J"},{"key":"3168_CR17","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.2337\/diacare.28.6.1510","volume":"28","author":"LM Welschen","year":"2005","unstructured":"Welschen LM, Bloemendal E, Nijpels G et al (2005) Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care 28:1510\u20131517","journal-title":"Diabetes Care"},{"issue":"Suppl 1","key":"3168_CR18","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1089\/dia.2008.0001","volume":"10","author":"N Poolsup","year":"2008","unstructured":"Poolsup N, Suksomboon N, Jiamsathit W (2008) Systematic review of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients. Diabetes Technol Ther 10(Suppl 1):S51\u2013S66","journal-title":"Diabetes Technol Ther"},{"key":"3168_CR19","first-page":"468","volume":"14","author":"A Towfigh","year":"2008","unstructured":"Towfigh A, Romanova M, Weinreb JE et al (2008) Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: a meta-analysis. Am J Manage Care 14:468\u2013475","journal-title":"Am J Manage Care"},{"key":"3168_CR20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2337\/dc10-1732","volume":"34","author":"WH Polonsky","year":"2011","unstructured":"Polonsky WH, Fisher L, Schikman CH et al (2011) Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care 34:262\u2013267","journal-title":"Diabetes Care"},{"key":"3168_CR21","doi-asserted-by":"crossref","first-page":"e486","DOI":"10.1136\/bmj.e486","volume":"344","author":"AJ Farmer","year":"2012","unstructured":"Farmer AJ, Perera R, Ward A et al (2012) Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ 344:e486","journal-title":"BMJ"},{"issue":"Suppl 1","key":"3168_CR22","first-page":"S1","volume":"28","author":"American Diabetes Association","year":"2005","unstructured":"American Diabetes Association (2005) Clinical practice recommendations 2005. Diabetes Care 28(Suppl 1):S1\u2013S79","journal-title":"Diabetes Care"},{"key":"3168_CR23","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1464-5491.1999.00166.x","volume":"16","author":"European Diabetes Policy Group","year":"1999","unstructured":"European Diabetes Policy Group (1999) A desktop guide to type 2 diabetes mellitus. Diabet Med J Br Diabet Assoc 16:716\u2013730","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"3168_CR24","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJM199010113231503","volume":"323","author":"ML Larsen","year":"1990","unstructured":"Larsen ML, H\u00f8rder M, Mogensen EF (1990) Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. N Engl J Med 323:1021\u20131025","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"3168_CR25","first-page":"S41","volume":"52","author":"MA Nauck","year":"2009","unstructured":"Nauck MA, Heinemann L, Haastert B et al (2009) A randomized, controlled trial of blood glucose self-monitoring in type 2-diabetic patients receiving conventional insulin treatment (abstract). Diabetologia 52(Suppl 1):S41","journal-title":"Diabetologia"},{"key":"3168_CR26","unstructured":"Matthaei S, Bierwirth R, Fritsche A, et al. (2008) Medikament\u00f6se antihyperglyk\u00e4mische Therapie des Diabetes mellitus Typ 2. In: Scherbaum WA, Haak T (eds) Evidenzbasierte Leitlinie der Deutschen Diabetes-Gesellschaft, available from www.arztbibliothek.de\/mdb\/downloads\/ddiabetesg\/antihyperglykaemische-therapie-lang.pdf [in German] (accessed 6 January, 2014)"},{"key":"3168_CR27","doi-asserted-by":"crossref","DOI":"10.1002\/0470023589","volume-title":"Applied mixed models in medicine","author":"H Brown","year":"2006","unstructured":"Brown H, Prescott R (2006) Applied mixed models in medicine. Wiley, Bognor Regis"},{"key":"3168_CR28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s001250050089","volume":"37","author":"EG Starostina","year":"1994","unstructured":"Starostina EG, Antsiferov M, Galstyan GR et al (1994) Effectiveness and cost-benefit analysis of intensive treatment and teaching programmes for type 1 (insulin-dependent) diabetes mellitus in Moscow\u2014blood glucose versus urine glucose self-monitoring. Diabetologia 37:170\u2013176","journal-title":"Diabetologia"},{"key":"3168_CR29","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.2337\/diacare.26.11.3080","volume":"26","author":"MC Riddle","year":"2003","unstructured":"Riddle MC, Rosenstock J, Gerich J (2003) The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 26:3080\u20133086","journal-title":"Diabetes Care"},{"key":"3168_CR30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/0003-4819-130-5-199903020-00002","volume":"130","author":"H Yki-J\u00e4rvinen","year":"1999","unstructured":"Yki-J\u00e4rvinen H, Ryysy L, Nikkila K, Tulokas T, Vanamo R, Heikkila M (1999) Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med 130:389\u2013396","journal-title":"Ann Intern Med"},{"key":"3168_CR31","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00125-005-0132-0","volume":"49","author":"H Yki-J\u00e4rvinen","year":"2006","unstructured":"Yki-J\u00e4rvinen H, Kauppinen-Makelin R, Tiikkainen M et al (2006) Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study. Diabetologia 49:442\u2013451","journal-title":"Diabetologia"},{"key":"3168_CR32","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1056\/NEJMoa075392","volume":"357","author":"RR Holman","year":"2007","unstructured":"Holman RR, Thorne KI, Farmer AJ et al (2007) Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes. N Engl J Med 357:1716\u20131730","journal-title":"N Engl J Med"},{"key":"3168_CR33","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.28.2.254","volume":"28","author":"HU Janka","year":"2005","unstructured":"Janka HU, Plewe G, Riddle MC, Kliebe-Frisch C, Schweitzer MA, Yki-J\u00e4rvinen H (2005) Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes. Diabetes Care 28:254\u2013259","journal-title":"Diabetes Care"},{"key":"3168_CR34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.diabres.2009.10.020","volume":"87","author":"MA Stone","year":"2010","unstructured":"Stone MA, Wilkinson JC, Charpentier G et al (2010) Evaluation and comparison of guidelines for the management of people with type 2 diabetes from eight European countries. Diabetes Res Clin Pract 87:252\u2013260","journal-title":"Diabetes Res Clin Pract"},{"key":"3168_CR35","doi-asserted-by":"crossref","first-page":"d4169","DOI":"10.1136\/bmj.d4169","volume":"343","author":"R Boussageon","year":"2011","unstructured":"Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M et al (2011) Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. Brit Med J 343:d4169","journal-title":"Brit Med J"},{"key":"3168_CR36","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1111\/dme.12071","volume":"30","author":"E Beluchin","year":"2013","unstructured":"Beluchin E, Baz L, M\u00fcller N et al (2013) Frequency of self-adjustment of insulin dose and metabolic control in type 2 diabetes\u2014is there an association? Diabet Med J Br Diabet Assoc 30:e91\u2013e94","journal-title":"Diabet Med J Br Diabet Assoc"},{"key":"3168_CR37","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1161\/CIRCULATIONAHA.107.733949","volume":"117","author":"A Turchin","year":"2008","unstructured":"Turchin A, Shubina M, Chodos AH, Einbinder JS, Pendergrass ML (2008) Effect of board certification on antihypertensive treatment intensification in patients with diabetes mellitus. Circulation 117:623\u2013628","journal-title":"Circulation"},{"key":"3168_CR38","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","volume":"355","author":"SE Kahn","year":"2006","unstructured":"Kahn SE, Haffner SM, Heise MA et al (2006) Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355:2427\u20132443","journal-title":"N Engl J Med"},{"key":"3168_CR39","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","volume":"281","author":"RC Turner","year":"1999","unstructured":"Turner RC, Cull CA, Frighi V, Holman RR (1999) Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. J Am Med Assoc 281:2005\u20132012","journal-title":"J Am Med Assoc"},{"key":"3168_CR40","doi-asserted-by":"crossref","first-page":"e3087","DOI":"10.1371\/journal.pone.0003087","volume":"3","author":"WA Scherbaum","year":"2008","unstructured":"Scherbaum WA, Ohmann C, Abholz HH, Dragano N, Lankisch M (2008) Effect of the frequency of self-monitoring blood glucose in patients with type 2 diabetes treated with oral antidiabetic drugs\u2014a multi-centre, randomized controlled trial. PLoS ONE 3:e3087","journal-title":"PLoS ONE"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-014-3168-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-014-3168-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-014-3168-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T10:33:42Z","timestamp":1716460422000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-014-3168-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,21]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["3168"],"URL":"https:\/\/doi.org\/10.1007\/s00125-014-3168-1","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"type":"print","value":"0012-186X"},{"type":"electronic","value":"1432-0428"}],"subject":[],"published":{"date-parts":[[2014,1,21]]}}}